Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

The use of sterically stabilized liposomes to treat asthma.

Konduri KS, Nandedkar S, Rickaby DA, Düzgüneş N, Gangadharam PR.

Methods Enzymol. 2005;391:413-27.

PMID:
15721394
2.

In vitro anti-mycobacterial activities of three species of Cola plant extracts (Sterculiaceae).

Adeniyi BA, Groves MJ, Gangadharam PR.

Phytother Res. 2004 May;18(5):414-8.

PMID:
15174004
3.

Efficacy of liposomal budesonide in experimental asthma.

Konduri KS, Nandedkar S, Düzgünes N, Suzara V, Artwohl J, Bunte R, Gangadharam PR.

J Allergy Clin Immunol. 2003 Feb;111(2):321-7.

PMID:
12589352
4.

Direct drug susceptibility test for tubercle bacilli by the sputum swab culture method.

Mathew S, Nair NG, Radhakrishna S, Gangadharam PR.

Int J Tuberc Lung Dis. 2000 Feb;4(2):168-73.

PMID:
10694096
5.

Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.

Gangadharam PR, Geeta N, Hsu YY, Wise DL.

Int J Tuberc Lung Dis. 1999 Jun;3(6):515-20.

PMID:
10383065
6.

Antimycobacterial activities of riminophenazines.

Reddy VM, O'Sullivan JF, Gangadharam PR.

J Antimicrob Chemother. 1999 May;43(5):615-23. Review.

PMID:
10382882
7.

DOTS and beyond: towards a holistic approach to the conquest of tuberculosis.

Gangadharam PR.

Int J Tuberc Lung Dis. 1998 Nov;2(11):943-4. No abstract available.

PMID:
9848619
8.

Clarithromycin for non-mycobacterial diseases?

Gangadharam PR.

Int J Tuberc Lung Dis. 1998 Oct;2(10):861-2. No abstract available.

PMID:
9783536
9.

Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.

Williams DL, Spring L, Collins L, Miller LP, Heifets LB, Gangadharam PR, Gillis TP.

Antimicrob Agents Chemother. 1998 Jul;42(7):1853-7.

10.

Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices.

Hsu YY, Gresser JD, Trantolo DJ, Lyons CM, Gangadharam PR, Wise DL.

J Biomed Mater Res. 1997 Apr;35(1):107-16.

PMID:
9104703
11.

Microbiology of nontuberculosis mycobacteria.

Gangadharam PR.

Semin Respir Infect. 1996 Dec;11(4):231-43. Review.

PMID:
8976577
12.

Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin.

Düzgüneş N, Flasher D, Reddy MV, Luna-Herrera J, Gangadharam PR.

Antimicrob Agents Chemother. 1996 Nov;40(11):2618-21.

13.

Pathobiological significance of colony morphology in Mycobacterium avium complex.

Reddy VM, Luna-Herrera J, Gangadharam PR.

Microb Pathog. 1996 Aug;21(2):97-109.

PMID:
8844653
14.

Mechanisms of isoniazid release from poly(d,l-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods.

Hsu YY, Gresser JD, Stewart RR, Trantolo DJ, Lyons CM, Simons GA, Gangadharam PR, Wise DL.

J Pharm Sci. 1996 Jul;85(7):706-13.

PMID:
8818994
15.

Chemotherapeutic activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium tuberculosis in C57BL/6 mice.

Reddy MV, Luna-Herrera J, Daneluzzi D, Gangadharam PR.

Tuber Lung Dis. 1996 Apr;77(2):154-9.

PMID:
8762850
16.

Polymerase chain reaction detection of Mycobacterium tuberculosis in formalin-fixed tissue.

Rish JA, Eisenach KD, Cave MD, Reddy MV, Gangadharam PR, Bates JH.

Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1419-23.

PMID:
8616575
17.

Antituberculosis activities of clofazimine and its new analogs B4154 and B4157.

Reddy VM, Nadadhur G, Daneluzzi D, O'Sullivan JF, Gangadharam PR.

Antimicrob Agents Chemother. 1996 Mar;40(3):633-36.

18.

In-vitro and intracellular antimycobacterial activity of trifluoperazine.

Reddy MV, Nadadhur G, Gangadharam PR.

J Antimicrob Chemother. 1996 Jan;37(1):196-7. No abstract available.

PMID:
8647767
19.

Mycobacterial dormancy.

Gangadharam PR.

Tuber Lung Dis. 1995 Dec;76(6):477-9. Review. No abstract available.

PMID:
8593366
20.

Antituberculosis activity of clarithromycin.

Luna-Herrera J, Reddy VM, Daneluzzi D, Gangadharam PR.

Antimicrob Agents Chemother. 1995 Dec;39(12):2692-5.

21.

Antimycobacterial activity of a new rifamycin derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (T9).

Reddy VM, Nadadhur G, Daneluzzi D, Dimova V, Gangadharam PR.

Antimicrob Agents Chemother. 1995 Oct;39(10):2320-4.

22.

In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli.

Luna-Herrera J, Reddy MV, Gangadharam PR.

J Antimicrob Chemother. 1995 Aug;36(2):355-63.

PMID:
8522465
23.

Beige mouse model for Mycobacterium avium complex disease.

Gangadharam PR.

Antimicrob Agents Chemother. 1995 Aug;39(8):1647-54. Review. No abstract available.

24.

Carryover of clofazimine into culture media.

Gangadharam PR, Reddy MV.

Antimicrob Agents Chemother. 1995 Jun;39(6):1388-9. No abstract available.

25.

Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies.

Jagannath C, Reddy MV, Kailasam S, O'Sullivan JF, Gangadharam PR.

Am J Respir Crit Care Med. 1995 Apr;151(4):1083-6.

PMID:
7697235
26.

Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes.

Gangadharam PR, Ashtekar DR, Flasher DL, Düzgüneş N.

Antimicrob Agents Chemother. 1995 Mar;39(3):725-30.

27.
28.

In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli.

Luna-Herrera J, Reddy MV, Gangadharam PR.

Antimicrob Agents Chemother. 1995 Feb;39(2):440-4.

29.

Human immunodeficiency virus and Mycobacterium avium complex coinfection of monocytoid cells results in reciprocal enhancement of multiplication.

Ghassemi M, Andersen BR, Reddy VM, Gangadharam PR, Spear GT, Novak RM.

J Infect Dis. 1995 Jan;171(1):68-73.

PMID:
7528254
30.
31.

Chemotherapy of tuberculosis under program conditions. With special relevance to India.

Gangadharam PR.

Tuber Lung Dis. 1994 Aug;75(4):241-4. No abstract available.

PMID:
7949068
32.
33.

Differences in infectivity of isogenic variants of Mycobacterium avium by oral route.

Reddy MV, Gangadharam PR.

Tuber Lung Dis. 1994 Apr;75(2):158-60. No abstract available.

PMID:
8032054
34.

Rapid assessment of mycobacterial growth inside macrophages and mice, using the radiometric (BACTEC) method.

Reddy MV, Srinivasan S, Andersen B, Gangadharam PR.

Tuber Lung Dis. 1994 Apr;75(2):127-31.

PMID:
8032045
35.

Contributions of animal and macrophage models to the understanding of host parasite interaction of Mycobacterium avium complex (MAC) disease.

Gangadharam PR, Reddy MV.

Res Microbiol. 1994 Mar-Apr;145(3):214-24. Review. No abstract available.

PMID:
7809475
36.

In vivo activity of paromomycin against susceptible and multidrug-resistant Mycobacterium tuberculosis and M. avium complex strains.

Kanyok TP, Reddy MV, Chinnaswamy J, Danziger LH, Gangadharam PR.

Antimicrob Agents Chemother. 1994 Feb;38(2):170-3.

37.

Activity of aminosidine (paromomycin) for Mycobacterium tuberculosis and Mycobacterium avium.

Kayok TP, Reddy MV, Chinnaswamy J, Danziger LH, Gangadharam PR.

J Antimicrob Chemother. 1994 Feb;33(2):323-7. No abstract available.

PMID:
8182014
39.

Experimental chemotherapy of tuberculosis using single dose treatment with isoniazid in biodegradable polymers.

Gangadharam PR, Kailasam S, Srinivasan S, Wise DL.

J Antimicrob Chemother. 1994 Feb;33(2):265-71.

PMID:
8182007
40.

Comparison of virulence of Mycobacterium avium complex (MAC) strains isolated from AIDS and non-AIDS patients.

Reddy VM, Parikh K, Luna-Herrera J, Falkinham JO 3rd, Brown S, Gangadharam PR.

Microb Pathog. 1994 Feb;16(2):121-30.

PMID:
8047000
41.

Drug resistance in tuberculosis: it's not always the patient's fault!

Gangadharam PR.

Tuber Lung Dis. 1993 Feb;74(1):65-7. No abstract available.

PMID:
8495025
42.
43.

Utility of beige mouse in leprosy research.

Gangadharam PR, Dhople AM.

Indian J Lepr. 1992 Oct-Dec;64(4):475-81.

PMID:
1308522
44.
45.

Heat shock treatment of macrophages causes increased release of superoxide anion.

Reddy MV, Gangadharam PR.

Infect Immun. 1992 Jun;60(6):2386-90.

46.

Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages.

Ashtekar D, Düzgünes N, Gangadharam PR.

J Antimicrob Chemother. 1991 Oct;28(4):615-7. No abstract available.

PMID:
1761459
47.

Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice.

Gangadharam PR, Ashtekar DA, Ghori N, Goldstein JA, Debs RJ, Düzgünes N.

J Antimicrob Chemother. 1991 Sep;28(3):425-35.

PMID:
1960123
49.

Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment.

Düzgüneş N, Ashtekar DR, Flasher DL, Ghori N, Debs RJ, Friend DS, Gangadharam PR.

J Infect Dis. 1991 Jul;164(1):143-51.

PMID:
2056201
50.

Sustained release of isoniazid in vivo from a single implant of a biodegradable polymer.

Gangadharam PR, Ashtekar DR, Farhi DC, Wise DL.

Tubercle. 1991 Jun;72(2):115-22.

PMID:
1949214

Supplemental Content

Loading ...
Support Center